Ultime notizie

NEW HOPE FOR THALASSAEMIA/SCD | UK Trial Of Lab Grown Red Blood Cells Begins
ADVANCED THERAPIES | Vertex, CRISPR To Submit Exa-Cel to FDA For β-Thalassaemia And Sickle Cell Disease
CDC | Many Children With Sickle Cell Anaemia In The US Not Receiving Lifesaving Screening And Treatment
CLINICAL NEWS | PYRUKYND® Receives Positive CHMP Opinion For The Treatment of PKD in Adults
NEWSLETTER | Iranian Blood Transfusion Organization (IBTO) August 2022
SAFER BLOOD | EU Patients Have Begun Receiving Transfusions With Hemanext ONE® RBC Processing & Storage System
WORLD PATIENT SAFETY DAY 2022 | Medication Without Harm: Know. Check. Ask.
SICKLE CELL DISEASE | African Health Ministers Launch Drive to Curb SCD’s Toll
A HISTORIC BREAKTHROUGH | UNICEF Signs First-Ever Malaria Vaccine Supply Contract With GSK
BREAKING NEWS | Bluebird’s Gene Therapy For β-Thalassaemia Wins US Approval

Italiano

Menu

Pagina iniziale
Chi siamo
Cosa facciamo
Malattie dell’emoglobina
Posizioni e Politiche
Pubblicazioni
Centro multimediale
- Notizie
- Newsletter
- Eventi
- Video
Contatti

Cerca per

Home/AtRisk

AtRisk

NOVITÀ

Ottobre 20, 2021

TIF Supports Administration Of COVID-19 Vaccine Booster Dose To Patients With Haemoglobin Disorders

Leggi di più »

Link rapidi

Per i pazienti
Per gli operatori sanitari
Per le associazioni
Per i sostenitori
Membri della TIF
Link utili
Mappa del sito

SCARICA LE APP

App ThaliMe

Iscriviti alla nostra Newsletter

Seguici

Facebook
X
LinkedIn
You Tube
Instagram
RSS

© Copyright 2025, All Rights Reserved |

Powered by Genestial

Transparency Statement | Privacy Policy

Pulsante per tornare all'inizio

Chiudi

Facebook
X
LinkedIn
You Tube
Instagram
RSS

Ricerca per: